SCHEMBL22192303

SCHEMBL22192303

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-n4c5ccccc5c5ccc6c7c8c(ccc7n(-c7ccccc7)c6c54)oc4ccccc48)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
SIRT2 Q8IXJ6 1/20 0.30
SIRT1 Q96EB6 1/20 0.30
GAA P10253 1/20 0.30
CA12 O43570 1/20 0.30
CA9 Q16790 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22192750 1.00 KDM4E (0.33) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192622 0.94 SMN1; SMN2 (0.34) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192514 0.94 SMN1; SMN2 (0.34) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL18619069 0.94 KDM4E (0.35) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192288 0.94 KDM4E (0.35) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192372 0.93 KDM4E (0.35) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192318 0.93 KDM4E (0.35) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192315 0.93 KDM4E (0.33) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192299 0.93 KDM4E (0.33) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL22192436 0.92 SMN1; SMN2 (0.34) KDM4ELMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus PIEZO1, OR10J3, EPCAM KDM4E 3529/4885LMNA 2806/4885MEN1 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.